Identity that remains with the package
The intelligent film is integrated with the vial, carton, or blister structure rather than presented as a detachable conventional label component.
AXIOGOV™ · Pharmaceutical Lifecycle Governance
Every medicine should carry
its own governed history.
AXIOGOV™ extends governed molecular identity and tamper-state awareness into the physical package itself. When medicine is verified, packaged, sealed, and certified under ALETHRA™ governance, integrated AXIO CHIP films bind that certified identity to the package and begin an immutable history of manufacture, packaging, location, time, and environmental context. When a vial cap is removed, a carton is opened, or a blister cavity is breached, the changed seal state is recorded and the applicable post-opening lifespan clock begins.
The film is the technology. The package becomes part of the governed record.
Identity
Package-level identity
State
Tamper-state awareness
Records
Immutable event records
Hi, I am ALETHA. I help you understand your data and prepare it for your practitioner. I do not make clinical decisions; your practitioner does.
ALETHRA™ governs; ALETHA™ guides. Learn more
Intelligence in motion5 intelligence domains
AnalyzingEvaluating HRV trend · ECG rhythm → autonomic-load context
Consent Protocol Record Ring & Bracelet Trends AXIS Events Labs
Inputs · Ring·Bracelet
The Integrity Gap
Pharmaceutical integrity
should continue through
the moment of access.
Medicines pass through manufacturers, distributors, pharmacies, clinics, caregivers, and patients. Along that path, conventional packaging can show that it has been opened, but it does not always preserve a persistent identity or a governed history of the package state. AXIOGOV™ brings the package into the governance architecture.
A physical state change when access occurs
Removing a cap, opening a carton seal, or breaching a blister cavity changes the monitored film state.
An immutable event instead of an assumption
The system preserves the certified package identity, intact state, and registered access event in an immutable history. A breach event establishes package access; administration or ingestion remains a separate clinical fact unless confirmed through an authorized workflow.
A lifecycle clock tied to physical state
Certification and sealing begin the package history. The first verified opening event starts the applicable post-opening lifespan clock, allowing authorized participants to evaluate time since opening against the governed stability or use window.
That gap matters across high-value peptides and compounded preparations, controlled medicines, complex medication schedules, and products exposed to substitution, diversion, or counterfeiting.
The Technology
Intelligence
integrated into
the package.
AXIOGOV™ does not depend on a separate black chip mounted on passive packaging. The AXIO CHIP is the engineered film itself: a continuous identity and state-aware material designed around the package it governs.
Vial Governance
The cap, the closure,
and the vial body.
On the vial, AXIO CHIP tamper film sits within the cap and closure architecture, and AXIO CHIP body film maintains persistent identity on the vial body.
Integrated AXIO CHIP films
- Tamper filmAXIO CHIP tamper film sits within the cap and closure architecture.
- Cap removalRemoving the cap changes the tamper-film state.
- Body filmAXIO CHIP body film maintains persistent identity on the vial body.
- One governed packageThe closure event and body identity remain logically associated with the same governed medicine package.
Carton and Blister Governance
The same governed film
across cartons and
blister packs.
Carton governance
AXIO CHIP film seal spans the carton opening. Opening, cutting, or tearing the seal changes its physical state. Carton identity remains associated with the protected medicine package.
Blister governance
AXIO CHIP lidding film is integrated across the blister structure. Push-through, cut, or peel access changes the monitored cavity state. Each registered cavity breach can support dispense-event traceability.
A cavity-breach event establishes that the protected dose cavity was accessed. When combined with the prescribed schedule, authorized dispensing record, and patient workflow, the immutable history supports dose-timing controls and detection of early, repeated, or out-of-sequence access. Ingestion remains a separate clinical fact unless independently confirmed.
How It Functions
A medicine package
that can account for meaningful change.
01 Identity and origin are established
The ALETHRA™ molecular certification is bound to the AXIO CHIP package identity during the authorized packaging workflow, together with the manufacture and packaging date, time, and location.
02 The protected history begins
At certification and sealing, the package history epoch begins. Governed environmental observations and custody events accumulate against the same immutable identity.
03 Access changes the film state
Cap removal, carton opening, or blister-cavity breach produces a physical change in the corresponding film. A compatible reader picks up that change, and the first verified access time is written to the AXIOGOV™ event record.
04 The post-opening lifespan clock begins
The first verified seal breach starts the governed post-opening lifespan clock for the applicable medicine, presentation, or cavity. The original opening epoch is preserved and cannot be reset.
05 The lifecycle becomes immutable history
Certification, origin, environmental history, custody, prescribed schedule context, seal state, access events, and lifespan-clock status are written to an append-only event history within the authorized governance environment.
06 Authorized stakeholders receive context
Manufacturers, pharmacies, clinicians, caregivers, patients, or other authorized participants can receive the lifecycle information, warnings, or refusal state appropriate to their role and jurisdiction.
Why It Matters Now
Medicine is becoming more
valuable, more distributed,
and more difficult
to govern.
Peptides and high-value preparations
Growing demand for peptides, compounded preparations, and other high-value medicines increases the importance of preserving identity, authorized origin, molecular certification, and opening state throughout distribution and use. Under ALETHRA™ governance, AXIOGOV™ carries the certified molecular identity into the sealed vial or package and preserves its access history.
Controlled medicines and the opioid crisis
Illegally manufactured fentanyl is frequently pressed into counterfeit pills made to resemble legitimate prescription medicines. For medicine verified and certified under ALETHRA™ governance, AXIOGOV™ links the certified contents to the sealed package and records access events. Schedule-aware event logic can identify early, repeated, or out-of-sequence access and support intervention. It complements rather than replaces emergency and overdose-prevention measures.
Older adults, caregivers, and complex schedules
Older adults often manage multiple medicines across several health conditions. AXIOGOV™ can compare immutable package-access events with authorized dosage timing, helping patients and caregivers recognize whether a protected dose has already been accessed or is being accessed too soon. Prescribing, dispensing, administration, and clinical decisions remain with qualified professionals.
Counterfeit, substituted, and diverted products
When ALETHRA™ has verified the medicine and certified it into the sealed package, AXIOGOV™ preserves the link between that certified molecular identity and the package. A missing, conflicting, duplicated, or physically inconsistent record can therefore trigger refusal, investigation, or escalation. Products outside that governed chain are not automatically certified by AXIOGOV™.
Accountability for authorized use
The immutable history provides time-stamped evidence of what was certified, which package carried it, and when protected doses or closures were accessed. That evidence helps distinguish authorized manufacture, prescribing, and dispensing from patient misuse, diversion, or access outside the prescribed schedule. It supports patient protection and defensible records for clinicians and pharmaceutical organizations without creating automatic legal immunity.
Pharmacies, clinics, and health systems
Package-level identity and access events can support tighter receiving, dispensing, inventory, recall, exception-review, and chain-of-custody workflows without replacing existing regulatory or professional controls.
Claims Boundaries
What the governed
record establishes,
and what requires
separate confirmation.
The governed record can establish
Separate confirmation may still be required for
The ALETHRA™ certified molecular identity bound to the sealed package, including when and where it was made and packaged
The composition of an ungoverned, substituted, or post-breach product
Intact or changed tamper-film state
That a product is universally counterfeit-proof
Carton opening
Who physically opened it without separate authorized identity controls
Blister-cavity breach and its timing against an authorized dosage schedule
Ingestion or physiological response unless independently confirmed
Vial cap-removal event
Correct dosing or administration
Immutable evidence of certified contents, package identity, and access sequence
That access was clinically appropriate or produced a clinical outcome
Time since the verified opening event and status against the governed post-opening lifespan policy
Medicine quality after an unrecorded environmental excursion or physical substitution
Enterprise Architecture
From a single package
to an accountable
medicine network.
AXIOGOV™ is designed for integration across pharmaceutical manufacturers, authorized compounders, distributors, pharmacies, clinics, hospitals, care organizations, and other qualified operators. Deployment can be structured around role-based access, jurisdictional control, provenance, exception handling, and audit requirements. The physical package becomes an evidence-bearing part of a wider governed workflow.
- Package identityPersistent identity associated with the authorized package workflow
- Tamper-state eventsObservable intact-to-changed film state
- Origin and environment historyPreserve manufacture and packaging location and time, followed by supported environmental observations from the sealing epoch forward
- Post-opening lifespan clockStart on the first verified seal breach, evaluate against the approved product-specific policy, and preserve the original opening epoch
- Authorized provenancePresent only when supported by integrated source records
- Role-based visibilityDisplay according to authorization and stakeholder role
- Exception reviewRoute mismatch or unexpected state for authorized review
- Recall supportUse package identity and event history as supporting context
- Immutable event historyPreserve append-only package-state records according to the approved architecture; corrections become linked events rather than overwrites
- Jurisdictional controlsApply applicable access, storage, and disclosure requirements
AXIOGOV™ Enterprise
Integrity should not stop when the medicine leaves the manufacturer.
AXIOGOV™ carries ALETHRA™ certified molecular identity, manufacture and packaging provenance, environmental history, physical-state awareness, prescribed timing context, and immutable lifecycle records into the vial, carton, and blister itself. The governed history begins at sealing; the verified opening event starts the medicine’s post-opening lifespan clock, creating a stronger foundation for pharmaceutical traceability, safer dose access, accountable use, and medicine integrity.
Governance Boundary
Molecular-identity claims apply to medicine verified, packaged, sealed, and certified within ALETHRA™ governance. AXIOGOV™ preserves that certification and subsequent package-access history. It does not replace licensed pharmacies, qualified healthcare professionals, regulatory serialization requirements, or emergency and overdose-prevention measures.